Prokidney (PROK) Accumulated Depreciation (2021 - 2025)
Prokidney (PROK) reported Accumulated Depreciation of $16.6 million for Q4 2025, up 50.04% year-over-year from $11.0 million in Q4 2024, and up 19.24% on a QoQ basis from $13.9 million in Q2 2025.
Prokidney (PROK) has 5 years of Accumulated Depreciation data on file, last reported at $16.6 million in Q4 2025.
- Quarterly Accumulated Depreciation rose 50.04% year-over-year to $16.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $16.6 million (up 50.04% YoY) and the FY2025 annual result came in at $16.6 million, up 50.04% from the prior year.
- Accumulated Depreciation improved to $16.6 million in Q4 2025 per PROK's latest filing, from $13.9 million in the prior quarter.
- Across five years, Accumulated Depreciation topped out at $16.6 million in Q4 2025 and bottomed at $2.3 million in Q4 2021.
- The 5-year median for Accumulated Depreciation is $8.0 million (2023), against an average of $8.5 million.
- The widest annual swing landed in 2022, when Accumulated Depreciation jumped 108.41%; it then soared 44.36% in 2024.
- Tracing PROK's Accumulated Depreciation over 5 years: stood at $2.3 million in 2021, then surged by 108.41% to $4.7 million in 2022, then surged by 62.32% to $7.6 million in 2023, then surged by 44.36% to $11.0 million in 2024, then surged by 50.04% to $16.6 million in 2025.
- Per Business Quant, the three latest PROK Accumulated Depreciation figures stand at $16.6 million (Q4 2025), $13.9 million (Q2 2025), and $12.4 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Prokidney | 259.72 Mn | 1.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.55 Mn |
| Jun 30, 2025 | 13.88 Mn |
| Mar 31, 2025 | 12.41 Mn |
| Dec 31, 2024 | 11.03 Mn |
| Sep 30, 2024 | 10.57 Mn |
| Jun 30, 2024 | 9.40 Mn |
| Mar 31, 2024 | 8.44 Mn |
| Dec 31, 2023 | 7.64 Mn |
| Sep 30, 2023 | 6.77 Mn |
| Jun 30, 2023 | 5.98 Mn |
| Mar 31, 2023 | 5.33 Mn |
| Dec 31, 2022 | 4.71 Mn |
| Sep 30, 2022 | 4.09 Mn |
| Dec 31, 2021 | 2.26 Mn |